Company Quick10K Filing
Precision Therapeutics
S-1 2019-10-30 Public Filing
10-Q 2019-09-30 Filed 2019-11-15
10-Q 2019-06-30 Filed 2019-08-19
10-Q 2019-03-31 Filed 2019-05-15
10-K 2018-12-31 Filed 2019-04-01
10-Q 2018-09-30 Filed 2018-11-14
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-15
10-K 2017-12-31 Filed 2018-04-02
10-Q 2017-09-30 Filed 2017-11-14
10-Q 2017-06-30 Filed 2017-08-14
10-Q 2017-03-31 Filed 2017-05-15
10-K 2016-12-31 Filed 2017-03-15
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-12
10-Q 2016-03-31 Filed 2016-05-23
10-K 2015-12-31 Filed 2016-03-16
10-Q 2015-09-30 Filed 2015-11-13
10-Q 2015-06-30 Filed 2015-08-10
10-Q 2015-03-31 Filed 2015-05-18
10-K 2014-12-31 Filed 2015-04-30
10-Q 2014-09-30 Filed 2014-11-12
10-Q 2014-06-30 Filed 2014-08-08
10-Q 2014-03-31 Filed 2014-05-15
10-K 2013-12-31 Filed 2014-03-27
10-Q 2013-09-30 Filed 2013-11-14
10-Q 2013-06-30 Filed 2013-08-14
10-Q 2013-03-31 Filed 2013-05-15
10-K 2012-12-31 Filed 2013-03-22
10-Q 2012-09-30 Filed 2012-11-15
10-Q 2012-06-30 Filed 2012-08-14
10-Q 2012-03-31 Filed 2012-05-15
10-K 2011-12-31 Filed 2012-04-16
10-Q 2011-09-30 Filed 2011-11-14
10-Q 2011-06-30 Filed 2011-08-15
10-Q 2011-03-31 Filed 2011-05-16
10-K 2010-12-31 Filed 2011-03-31
10-Q 2010-09-30 Filed 2010-11-12
10-Q 2010-06-30 Filed 2010-08-13
10-Q 2010-03-31 Filed 2010-05-17
10-K 2009-12-31 Filed 2010-03-31
8-K 2020-03-19 Enter Agreement, Sale of Shares, Exhibits
8-K 2020-03-15 Enter Agreement, Sale of Shares, Exhibits
8-K 2020-02-19 Officers, Exhibits
8-K 2020-02-05 Enter Agreement, Sale of Shares, Exhibits
8-K 2020-01-31 Enter Agreement, Sale of Shares, Exhibits
8-K 2020-01-24 Regulation FD, Exhibits
8-K 2020-01-21 Officers
8-K 2020-01-01 Officers, Exhibits
8-K 2019-12-18 Shareholder Vote
8-K 2019-12-12 Enter Agreement, Sale of Shares, Exhibits
8-K 2019-11-26 Enter Agreement, Exhibits
8-K 2019-11-15 Earnings, Exhibits
8-K 2019-10-25 Amend Bylaw, Other Events, Exhibits
8-K 2019-10-24 Enter Agreement, Sale of Shares, Exhibits
8-K 2019-10-23 Shareholder Vote
8-K 2019-10-01 Enter Agreement, Exhibits
8-K 2019-09-27 Enter Agreement, Sale of Shares, Exhibits
8-K 2019-09-23 Regulation FD, Exhibits
8-K 2019-08-19 Earnings, Exhibits
8-K 2019-07-05 Sale of Shares, Exhibits
8-K 2019-06-13 Amend Bylaw, Exhibits
8-K 2019-06-10 Amend Bylaw, Exhibits
8-K 2019-05-30 Enter Agreement, Exhibits
8-K 2019-05-21 Enter Agreement, Exhibits
8-K 2019-05-17 Regulation FD, Exhibits
8-K 2019-05-16 Exhibits
8-K 2019-05-15 Earnings, Exhibits
8-K 2019-05-07 Enter Agreement, Exhibits
8-K 2019-04-04 M&A, Officers, Amend Bylaw, Exhibits
8-K 2019-04-01 Earnings, Exhibits
8-K 2019-03-27 Enter Agreement, Exhibits
8-K 2019-03-22 Amend Bylaw, Shareholder Vote, Exhibits
8-K 2019-03-13 Other Events, Exhibits
8-K 2019-03-08 Other Events, Exhibits
8-K 2019-03-05 Other Events, Exhibits
8-K 2019-02-27 Enter Agreement, Exhibits
8-K 2019-02-26 Other Events, Exhibits
8-K 2019-02-19 Other Events, Exhibits
8-K 2019-02-07 Other Events, Exhibits
8-K 2019-02-06 Enter Agreement, Sale of Shares, Exhibits
8-K 2019-01-25 Other Events, Exhibits
8-K 2019-01-22 Other Events, Exhibits
8-K 2019-01-18 Other Events, Exhibits
8-K 2019-01-17 Other Events, Exhibits
8-K 2019-01-08 Enter Agreement, Sale of Shares, Exhibits
8-K 2018-12-28 Shareholder Vote
8-K 2018-12-03 Other Events, Exhibits
8-K 2018-11-30 Enter Agreement, Exhibits
8-K 2018-11-16 Other Events
8-K 2018-11-14 Other Events, Exhibits
8-K 2018-11-14 Earnings, Other Events, Exhibits
8-K 2018-11-06 Other Events, Exhibits
8-K 2018-10-30 Other Events, Exhibits
8-K 2018-10-26 Enter Agreement, Regulation FD, Exhibits
8-K 2018-09-28 Enter Agreement, Sale of Shares, Exhibits
8-K 2018-08-06 Officers
8-K 2018-06-28 Enter Agreement, Regulation FD, Exhibits
8-K 2018-04-24 Accountant, Exhibits
8-K 2018-04-20 Other Events, Exhibits
8-K 2018-04-02 Earnings, Exhibits
8-K 2018-04-01 Enter Agreement, Regulation FD, Exhibits
8-K 2018-01-31 Enter Agreement, Amend Bylaw, Exhibits
8-K 2018-01-11 Enter Agreement, Sale of Shares, Regulation FD, Exhibits
8-K 2018-01-09 Other Events
8-K 2018-01-05 Enter Agreement, Other Events, Exhibits
8-K 2017-12-28 Officers, Amend Bylaw, Shareholder Vote, Exhibits
8-K 2017-12-28 Other Events

Precision Therapeutics Financials

AIPT Metrics, Comps, Filings

Quarterly | Annual

Business

Precision Therapeutics Inc (the "Company" or "Precision") is a healthcare products and services company that is expanding its business to take advantage of emerging areas of the dynamic healthcare market through sales of its products, through its partnership and its pending merger with Helomics Holding Corporation ("Helomics") and through pursuit of other strategic relationships to build value. Precision's business highlights include:

- Precision produces and sells the STREAMWAY® System, which it considers to be the best solution to solve the issue of medical waste disposal, with a cost-effective and environmentally friendly technology which provides infection control associated with toxic waste management. Precision has historically focused on growing the market for this product in the U.S. and are developing international markets.

· Precision has acquired 25% of the capital stock of Helomics and intends to consummate a merger with Helomics that is described elsewhere in this report, a pioneering Contract Research Organization ("CRO") Services company that bridges two significant areas of the healthcare industry: "Precision Medicine" and "Big Data". Precision has identified the CRO market as a burgeoning sector with significant growth potential. Precision is also partnering with Helomics in creating joint venture arrangements.


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Quarterly)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Quarterly)

Operating, Investing, Financing

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Conformis (CFMS) 127,869 48% -4.3 -45% 73,289 53,389 79,589 37,949 -32,915 -27,325 117,871
Northern Technologies International (NTIC) 113,086 32% 16.5 8% 67,511 10,916 55,750 17,780 5,663 6,518 107,229
Invacare (IVC) 260,927 28% 75.7 -4% 847,405 531,926 939,627 262,330 -35,889 5,263 398,168
Lakeland Industries (LAKE) 96,208 34% 15.9 2% 99,104 14,863 79,620 27,271 2,076 5,578 88,423
Shiloh Industries (SHLO) 94,685 9% 7.8 -3% 651,691 484,177 1,054,707 90,576 -19,947 42,453 329,060
Virco Manufacturing (VIRC) 66,783 39% 4.8 5% 139,865 75,316 164,250 64,668 6,692 16,737 80,443
Precision Therapeutics (AIPT) 13,264 72% 105.9 0% 5,416 2,389 1,320 951 0 123 13,054
Alpha Pro Tech (APT) 48,716 37% 11.9 7% 37,864 4,621 35,746 13,130 2,665 3,665 43,610
Hudson Technologies (HDSN) 28,561 10% -18.2 -11% 204,206 149,253 162,027 15,484 -23,276 -6,358 116,006
Rewalk Robotics (RWLK) 23,214 54% -0.8 -42% 28,426 14,311 3,692 2,010 -11,976 -11,972 9,493
Nanovibronix (NAOV) 19,155 69% -3.7 -150% 3,070 840 443 307 -4,601 -4,568 16,897
Milestone Scientific (MLSS) 47,202 69% -10.0 -75% 6,243 7,647 6,074 4,179 -4,661 -4,564 45,491
Myomo (MYO) 13,064 73% -1.1 -131% 6,083 1,664 2,317 1,696 -7,952 -7,952 8,660
Industrial Services of America (IDSA) 9,385 1% -9.3 -13% 24,547 16,631 41,558 276 -3,228 -1,712 15,855
Allied Healthcare Products (AHPI) 8,790 17% -10.1 -10% 15,479 4,202 32,089 5,420 -1,489 -838 8,487
BRP (DOOO)
Ocugen (OCGN) 0.4 -150% 23,619 36,712 0 -900 -35,424 -34,628 -14,394
XPEL (XPEL) 35% -0.7 16% 47,406 17,347 65,712 22,899 7,517 10,348 -6,897
Predictive Oncology (POAI) 62% 0.0 -8% 31,882 11,168 1,064 664 -2,543 -2,060 -99
Steel Partners Holdings (SPLP) 32% 2.0 1% 2,345,718 1,828,035 1,197,598 388,309 33,977 151,171 301,966

Balance Sheet ($'000)2011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-30
Cash78123221021337313732810213140244163447,7334,8561,5365836341,7642,0861,1607667662,2331,004210
Accounts Receivable1950194040971028397641502395890161438532439694592137242315239
Inventory9892134145141108101122392361316367301258237232257292289272249242239265273245278
PP&E5544431237175247247278275267258252284300302309316343355360361394491531
Assets2744463414443708114446375939979731,2379017257458,4165,6324,0512,8951,9172,8085,4664,5323,4993,6245,9994,0015,416
Accounts Payable7207317287237346126616361,0621,1031,6251,5782,1952,4642,4741,139650792750648220795775140186166409
Long-Term Debt1,3901,6861,77464856137997900
Liabilities2,7493,1493,2942,6733,6733,6553,9351,8453,8122,6544,1965,0726,4176,2706,8902,6021,5201,5202,1091,9061,8841,4841,3331,2179327846392,389
Stockholders' Equity-2,475-2,703-2,953-2,229-3,303-2,845-3,492-1,209-3,218-1,657-3,224-3,835-5,516-5,545-6,1445,8144,1132,531785129243,9833,1992,2822,6925,2163,3623,027
Income Statement ($'000)2011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-30
Revenue20742352901282271088270318397166151234861839785135140175107153220412359330
Cost of Revenue1143147043423926553198135121968420105863726323722296011710983
Gross Profit9319-18468618882273922026345551506679114910810713885124160294250247
R&D510581297428118131727263585981122100801048470696594
SG&A4902,6305982,5321,3491,9079973,3601,8451,3841,6501,0631,9641069959281,8741,7972,3658716101,2802,4469232,3971,7671,2841,384
Tax0000000
Net Income-2,856-1,717-2,102-1,176-3,975-2,154-1,617-1,736-1,115-2,365-226-1,185
Cash Flow ($'000)2011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-30
Cash Operating-596-250-403-940-1,183-1,213-1,752-195-1,195-229-5-209-4,423-2,850-1,588-1,197-920-677-1,156-915-1,322-1,694-1,413-962
Cash Investing0000-58-43-87-1-351-80-16-37-1,819244971181-2,336-1223146-101-141
Cash Financing6411503141,3001,0051,4481,8681051,4340025012,1281086001,6263,81501,3003,015285309